145 related articles for article (PubMed ID: 35955107)
1. A Qualitative Exploration of the Functional, Social, and Emotional Impacts of the COVID-19 Pandemic on People Who Use Drugs.
Kelly EL; Reed MK; Schoenauer KM; Smith K; Scalia-Jackson K; Kay Hill S; Li E; Weinstein L
Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35955107
[TBL] [Abstract][Full Text] [Related]
2. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
[TBL] [Abstract][Full Text] [Related]
3. Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.
Galarneau LR; Hilburt J; O'Neill ZR; Buxton JA; Scheuermeyer FX; Dong K; Kaczorowski J; Orkin AM; Barbic SP; Bath M; Moe J; Miles I; Tobin D; Grier S; Garrod E; Kestler A
PLoS One; 2021; 16(7):e0255396. PubMed ID: 34324589
[TBL] [Abstract][Full Text] [Related]
4. "The idea is to help people achieve greater success and liberty": A qualitative study of expanded methadone take-home access in opioid use disorder treatment.
Suen LW; Castellanos S; Joshi N; Satterwhite S; Knight KR
Subst Abus; 2022; 43(1):1143-1150. PubMed ID: 35499469
[No Abstract] [Full Text] [Related]
5. Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation.
Frueh L; Collins AB; Newman R; Barnett NP; Rich JD; Clark MA; Marshall BDL; Macmadu A
Harm Reduct J; 2023 Feb; 20(1):14. PubMed ID: 36739417
[TBL] [Abstract][Full Text] [Related]
6. Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder.
Clingan SE; Cousins SJ; Lin C; Nguyen TE; Hser YI; Mooney LJ
Ann Med; 2023 Dec; 55(1):480-489. PubMed ID: 36692029
[TBL] [Abstract][Full Text] [Related]
7. Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland.
Patel EU; Grieb SM; Winiker AK; Ching J; Schluth CG; Mehta SH; Kirk GD; Genberg BL
Harm Reduct J; 2024 May; 21(1):91. PubMed ID: 38720307
[TBL] [Abstract][Full Text] [Related]
8. The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis.
Mitra S; Bouck Z; Larney S; Zolopa C; Høj S; Minoyan N; Upham K; Rammohan I; Mok WY; Hayashi K; Milloy MJ; DeBeck K; Scheim A; Werb D
Harm Reduct J; 2024 May; 21(1):94. PubMed ID: 38750575
[TBL] [Abstract][Full Text] [Related]
9. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada.
Ali F; Russell C; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
Int J Drug Policy; 2021 Jul; 93():103237. PubMed ID: 33893026
[TBL] [Abstract][Full Text] [Related]
10. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.
Schofield J; Dumbrell J; Matheson C; Parkes T; Bancroft A
BMC Public Health; 2022 Mar; 22(1):500. PubMed ID: 35287630
[TBL] [Abstract][Full Text] [Related]
11. A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island.
Collins AB; Edwards S; McNeil R; Goldman J; Hallowell BD; Scagos RP; Marshall BDL
Int J Drug Policy; 2022 May; 103():103626. PubMed ID: 35228056
[TBL] [Abstract][Full Text] [Related]
12. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
[TBL] [Abstract][Full Text] [Related]
13. "As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crises.
Jaffe K; Blawatt S; Lehal E; Lock K; Easterbrook A; MacDonald S; Harrison S; Lajeunesse J; Byres D; Schechter M; Oviedo-Joekes E
Harm Reduct J; 2023 Apr; 20(1):51. PubMed ID: 37060027
[TBL] [Abstract][Full Text] [Related]
14. Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada.
Minoyan N; Høj SB; Zolopa C; Vlad D; Bruneau J; Larney S
Harm Reduct J; 2022 Apr; 19(1):38. PubMed ID: 35436936
[TBL] [Abstract][Full Text] [Related]
15. A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19.
Lockard R; Priest KC; Gregg J; Buchheit BM
Subst Abus; 2022; 43(1):1150-1157. PubMed ID: 35499402
[No Abstract] [Full Text] [Related]
16. "We have to be uncomfortable and creative": Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia.
Aronowitz SV; Engel-Rebitzer E; Lowenstein M; Meisel Z; Anderson E; South E
SSM Qual Res Health; 2021 Dec; 1():100013. PubMed ID: 34870265
[TBL] [Abstract][Full Text] [Related]
17. The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months.
Bennett AS; Townsend T; Elliott L
Int J Drug Policy; 2022 Mar; 101():103554. PubMed ID: 34911010
[TBL] [Abstract][Full Text] [Related]
18. 'More of the same, but worse than before': A qualitative study of the challenges encountered by people who use drugs in Nova Scotia, Canada during COVID-19.
Comeau E; Bonn M; Wildeman S; Herder M
PLoS One; 2023; 18(4):e0283979. PubMed ID: 37018353
[TBL] [Abstract][Full Text] [Related]
19. Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis.
Walters SM; Bolinski RS; Almirol E; Grundy S; Fletcher S; Schneider J; Friedman SR; Ouellet LJ; Ompad DC; Jenkins W; Pho MT
Addict Sci Clin Pract; 2022 Apr; 17(1):24. PubMed ID: 35468860
[TBL] [Abstract][Full Text] [Related]
20. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.
Rains A; York M; Bolinski R; Ezell J; Ouellet LJ; Jenkins WD; Pho MT
Harm Reduct J; 2022 Nov; 19(1):128. PubMed ID: 36403075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
